Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00406
|
|||||
| Drug Name |
Tacrolimus
|
|||||
| Synonyms |
(-)-FK 506; 15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone; 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN; Advagraf; Advagraf (TN); FK 506; FK5; FK506; FR 900506; FR-900506; FR900506; Fk-506; Fujimycin; Graceptor; K506; L 679934; L-679934; LCP-Tacro; Modigraf; Prograf; Prograf (TN); Protopic; Protopic (TN); Protopy; Tacarolimus; Tacrolimus (INN); Tacrolimus (Prograf); Tacrolimus (anhydrous); Tacrolimus anhydrous; Tsukubaenolide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Organ transplant rejection [ICD11: NE84] | Approved | [1] | |||
| Therapeutic Class |
Immunosuppressive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C44H69NO12
|
|||||
| Canonical SMILES |
CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
|
|||||
| InChI |
InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1
|
|||||
| InChIKey |
QJJXYPPXXYFBGM-LFZNUXCKSA-N
|
|||||
| CAS Number |
CAS 104987-11-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 804 | Topological Polar Surface Area | 178 | ||
| Heavy Atom Count | 57 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 12 | |||
| XLogP |
2.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10299743
, 103164549
, 103939344
, 104178757
, 104222107
, 104634734
, 109693101
, 118048657
, 119525750
, 12013904
, 124757870
, 124766122
, 124892446
, 124892447
, 124892448
, 14815954
, 14889261
, 24841759
, 26703416
, 26705532
, 26705535
, 26713140
, 26715494
, 26756858
, 29216422
, 36888289
, 4572
, 46506004
, 47574395
, 48020022
, 50111459
, 50111460
, 53788265
, 57404698
, 74380484
, 76558282
, 7887491
, 7980719
, 8150098
, 832905
, 842004
, 85788970
, 91011629
, 92308089
, 92310166
, 92711966
, 96025241
, 99301078
, 99302128
, 99436940
|
|||||
| ChEBI ID |
CHEBI:93221
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Tacrolimus was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.